S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
Latest› Regulation› Story
Regulation · September 23, 2026

CFTC tightens scrutiny on 'mention market' event contracts tied to individual actions

New staff advisory signals higher bar for exchanges listing contracts that settle on a person's words, attendance, or interactions.

CFTC tightens scrutiny on 'mention market' event contracts tied to individual actions Photo · James O'Connell for InvestLin

The Commodity Futures Trading Commission has signaled a tougher stance on a growing segment of event contracts that hinge on the behavior of a named individual. In a staff advisory issued September 22, 2026, the agency's Division of Market Oversight told designated contract markets (DCMs) that contracts settling on whether a person says certain words, attends a specific event, or interacts with another individual are "presumptively susceptible to manipulation."

That designation shifts the burden to exchanges to prove adequate safeguards exist before such products can be listed. It effectively makes it harder for platforms to use the streamlined self-certification process under Part 40 of CFTC regulations. While the advisory does not impose new legal obligations or ban these contracts outright, it signals that the commission will apply Core Principle 3 of the Commodity Exchange Act—which bars DCMs from listing products readily susceptible to manipulation—to any contract where a single person's conduct determines the outcome.

Manipulation risks and the Santos precedent

The advisory follows the CFTC's first-ever enforcement action for manipulation in a prediction market. On July 31, 2026, the agency settled charges against former Representative George Santos, who had traded an event contract based on his own attendance at the 2026 State of the Union address while posting misleading social media statements to influence the contract's price. Santos was ordered to disgorge $17,569.98 in profits, pay a $17,500 civil penalty, and accept a three-year trading ban on CFTC-registered platforms.

The advisory's logic is that "mention market" contracts differ fundamentally from most event contracts, which settle on externally generated outcomes like Federal Reserve rate decisions, election results, or aggregate sports scores. Those outcomes lie outside any single person's control. Whether a podcast host says a catchphrase on a live stream does not. That distinction creates manipulation risks that regulators say are difficult to manage.

By the numbers
$17,569.98
disgorged profits in Santos case
$17,500
civil penalty against Santos
1,600+
event contracts listed by 2025
12
new DCMs since Jan 2025

People closest to the settlement outcome—such as a speaker's staff, a guest list for a private event, or someone with access to a prepared script—often have advance knowledge of whether the triggering condition will be met. That information is material, nonpublic, and largely undetectable by surveillance systems calibrated for traditional derivatives. Moreover, the individual whose conduct determines settlement can be pressured or socially engineered into fulfilling—or failing to fulfill—the contract's conditions, sometimes without any observable market signal.

Four factors for evaluating mention market contracts

The advisory outlines four factors DMO staff will weigh when reviewing any mention market submission:

  • Whether the controlling individual is bound by independent legal, professional, or fiduciary obligations that create a credible deterrent against manipulation.
  • Whether the contract is vulnerable to manipulation by proxy—through pressure applied to the individual rather than by them directly.
  • Whether the relevant conduct is independently verifiable and subject to substantial public scrutiny, a bar the advisory indicates will be hard to clear for actions taken in informal or private settings.
  • Whether the exchange has implemented surveillance and position controls specifically calibrated to the risks each contract presents, including using public disclosure records to identify known insiders.

For financial advisors and wealth management professionals whose clients have exposure to prediction market platforms—or who are evaluating event contracts as part of broader alternative allocation discussions—the advisory adds another layer of regulatory uncertainty to a sector already navigating a complex oversight landscape. The CFTC has designated 12 new DCMs since January 2025, and by 2025 more than 1,600 event contracts were listed on U.S. prediction markets. That growth has drawn congressional attention, with more than 10 bills targeting the sector introduced since January 2026.

The advisory also comes amid broader regulatory scrutiny of alternative investments and market structures. For instance, maritime regulators have warned about shadow fleets affecting trade and portfolios, and global regulators have flagged AI concentration risks. Meanwhile, the partnership between Gemini and Apex has brought regulated event contracts to retail brokerages, and prediction markets are drawing young investors, blurring the line between betting and investing.

As the CFTC tightens its approach, exchanges will need to demonstrate robust compliance measures to list such contracts. The advisory does not specify a timeline for reviews, but it makes clear that the commission will not hesitate to reject submissions that fail to meet the heightened bar.

JO
About the author

James O'Connell

Regulation & Compliance Editor · Washington, D.C.

Covers the SEC, FINRA, DOL and state regulators from Washington, D.C.

Next story · Don't miss

Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors

Bankruptcy court approves sale of 30 properties, but investor recoveries remain uncertain amid fee disputes and arbitration hurdles.

Read the story →
Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors